| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6072007 | Journal of the American Academy of Dermatology | 2014 | 7 Pages |
Abstract
Using recently published appropriate-use criteria, 72.0% of skin cancers at this institution were appropriate for MMS. Tumor location was the most important factor in determining appropriate use.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Adam B. MD, James W. MD, Mark A. MD,